Clinical Trial Update: Ozurdex for Retinal Vein Occlusion Study (ORVO Study) [Phase 2, Phase 3]

View source ↗

Summary

This update reports results from the ORVO study evaluating Ozurdex (dexamethasone intravitreal implant) for retinal vein occlusion, with the trial (Phase 2/Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Johns Hopkins University | Conditions: Retinal Vein Occlusion | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-04-03